Danitracen

This classification denotes a serotonin antagonist with the molecular formula C20H21NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SD507F5T2W, chemically known as 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol but generally known as danitracen, which bears US NIH Compound Identifier 35758. European Medicines Agency schedules Danitracen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06900MIG. The term DANITRACEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). DANITRACEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule danitracen under HS 29333999 and SITC 51574. As of Q4 2014, DANITRACEN remains the US FDA Preferred Term for this commodity. Danitracen bears US NLM identifiers UMLS ID C0650227 and NCI Concept Code C72730. SMILES: OC1c2c(/C(=C3/CCN(CC3)C)c3c1cccc3)cccc2.